Citation Impact
Citing Papers
Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches
2009 StandoutScienceNobel
Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response
2013 StandoutNobel
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
2009
Tissue expression of PD-L1 mediates peripheral T cell tolerance
2006
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection
2005 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Constitutive Expression and Costimulatory Function of LIGHT/TNFSF14 on Human Melanoma Cells and Melanoma-Derived Microvesicles
2005
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
In Vivo Role of Flt3 Ligand and Dendritic Cells in NK Cell Homeostasis
2010
Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response
2005
Structure and function of the spleen
2005 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
2013
The PD-1/PD-Ls pathway and autoimmune diseases
2014
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
2015
The Roles of the New Negative T Cell Costimulatory Pathways in Regulating Autoimmunity
2004
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
The PD-1–PD-L pathway in immunological tolerance
2006 StandoutNobel
Homing of antibody secreting cells
2003
Regulation of Receptor Activator of NF-κB Ligand-induced Osteoclastogenesis by Endogenous Interferon-β (INF-β) and Suppressors of Cytokine Signaling (SOCS)
2002
B7‐H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK)
2005
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Central tolerance: learning self-control in the thymus
2005
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
2005
Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
2010
The confluence of radiotherapy and immunotherapy
2012
Requirement for Lymphoid Tissue-Inducer Cells in Isolated Follicle Formation and T Cell-Independent Immunoglobulin A Generation in the Gut
2008
Lymphoid organ development: from ontogeny to neogenesis
2006
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Inhibitory B7-family molecules in the tumour microenvironment
2008
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
2015
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
Balancing co-stimulation and inhibition with BTLA and HVEM
2006
Osteoclast differentiation and activation
2003 StandoutNature
Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity
2004
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
2008
Intestinal IgA Synthesis: A Primitive Form of Adaptive Immunity That Regulates Microbial Communities in the Gut
2006
Origin and physiological roles of inflammation
2008 StandoutNature
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Intestinal IgA synthesis: regulation of front-line body defences
2003 StandoutNobel
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways
2008
High endothelial venules (HEVs) in human melanoma lesions
2012
Shedding Light on Immunotherapy for Cancer
2004
Transforming activity of the lymphotoxin-β receptor revealed by expression screening
2005
Cancer-related inflammation
2008 StandoutNature
Programmed cell removal: a new obstacle in the road to developing cancer
2011
PD‐1 ligands expressed on myeloid‐derived APC in the CNS regulate T‐cell responses in EAE
2008
Carboxy-terminal domain of AID required for its mRNA complex formation in vivo
2009 StandoutNobel
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
Plasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma
2005
Interleukin-10 and the immune response against cancer: a counterpoint
2005
A mutation of Ikbkg causes immune deficiency without impairing degradation of IκBα
2010 StandoutNobel
The role of herpesvirus entry mediator as a negative regulator of T cell–mediated responses
2005
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Aire
2009
Generation and Characterization of B7-H4/B7S1/B7x-Deficient Mice
2006
Dependence of Self-Tolerance on TRAF6-Directed Development of Thymic Stroma
2005 Science
A critical role for the programmed death ligand 1 in fetomaternal tolerance
2005
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
Isolated Lymphoid Follicle Formation Is Inducible and Dependent Upon Lymphotoxin-Sufficient B Lymphocytes, Lymphotoxin β Receptor, and TNF Receptor I Function
2003
Targeting the Primary Tumor to Generate CTL for the Effective Eradication of Spontaneous Metastases
2007
Two distinctive pathways for recruitment of naïve and primed IgM+B cells to the gut lamina propria
2005 StandoutNobel
Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut
2004 StandoutNobel
THE B7 FAMILY REVISITED
2005 Standout
Cutting Edge: Programmed Death-1 Defines CD8+CD122+ T Cells as Regulatory versus Memory T Cells
2010
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection
2007
Blocking Programmed Death-1 Ligand-PD-1 Interactions by Local Gene Therapy Results in Enhancement of Antitumor Effect of Secondary Lymphoid Tissue Chemokine
2004
The future of immune checkpoint therapy
2015 StandoutScienceNobel
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
A crucial role for HVEM and BTLA in preventing intestinal inflammation
2008
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive Immunity
2011
Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell–Mediated Killing
2013
Developmental sequence in small groups.
1965 Standout
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
Intrahepatic cholestasis of pregnancy
2009
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability
2007 StandoutNobel
Coordination between NF-κB family members p50 and p52 is essential for mediating LTβR signals in the development and organization of secondary lymphoid tissues
2005
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment
2007
Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer
2005
Antibody to Langerin/CD207 localizes large numbers of CD8α + dendritic cells to the marginal zone of mouse spleen
2009 StandoutNobel
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
2006
Works of Robert Chin being referenced
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
2009
Distinction of Mouse Interferon-α Subtypes by Polymerase Chain Reaction Utilizing Consensus Primers and Type-Specific Oligonucleotide Probes
1994
Priming of naive T cells inside tumors leads to eradication of established tumors
2004
Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues
2003
Recruitment and Activation of Naive T Cells in the Islets by Lymphotoxin β Receptor-Dependent Tertiary Lymphoid Structure
2006
Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia
2000
Lymphotoxin pathway directs thymic Aire expression
2003
Signaling via LTβR on the lamina propria stromal cells of the gut is required for IgA production
2002
The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function
2002
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
2011
Obstetric cholestasis in Hong Kong--local experience with eight consecutive cases.
2007
A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development
2004
B Cells Control the Migration of a Subset of Dendritic Cells into B Cell Follicles Via CXC Chemokine Ligand 13 in a Lymphotoxin-Dependent Fashion
2002
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection
2004
THE PLANNING OF CHANGE
1969
Lymphotoxin Pathway-Directed, Autoimmune Regulator-Independent Central Tolerance to Arthritogenic Collagen
2006
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection
2004